Combination of specific monoclonal antibodies allow identification of soluble aggregates of by sandwich ELISA
- 1 Department of Applied Molecular Chemistry, Graduate School of Industrial Technology, Nihon University, Chiba, Japan
- 2 Department of Applied Molecular Chemistry, College of Industrial Technology, Nihon University, Chiba, Japan
- 3 Department of Sustainable Engineering, College of Industrial Technology, Nihon University, Chiba, Japan
- 4 Immuno Probe Co., Ltd., Ranzan, Japan
- 5 Department of Social Medicine, School of Public Health, Zhejiang University, Hangzhou, China
- 6 Department of Applied Molecular Chemistry, Graduate School of Industrial Technology, Nihon University, Chiba, Japan
Abstract
Aggregate amyloid beta protein 1-42 (A β 1-42 ) can typically be found in the early stage of Alzheimer’s disease (AD). A β 1-42 self-assembles and is highly toxic to neurons. Thus, recognizing aggregated A β 1-42 is very important for elucidation of A β 1-42 structure and for the diagnosis of AD. In this study, the specificity of the 79-3 monoclonal antibody against soluble aggre- gate A β 1-42 was measured by sandwich Enzyme-Linked Immuno Sorbent Assay (ELISA). Eight mono clonal antibodies against both soluble aggregates and amorphous aggregates were used as primary antibodies. Soluble aggregates and amorphous aggregates were used as antigen. As secondary antibody, HRP was labeled with the 79-3 monoclonal antibody. The reactivity of the 79-3 monoclonal antibody against soluble aggregates was confirmed in all combinations, but little reactivity against amorphous aggregates was found. Furthermore, we performed the above sandwich ELISA using the 37-11 antibody, which is reac tive a gainst large oval aggregates (LOA) that occur in micro aggregates, instead of the 79-3 an tibody. T he 77-3 antibody is 1 of the 8 monoclonal antibo dies against soluble aggregates; amorphous aggregates also reacted with the 37-11 antibody. These re sults indicated that soluble aggregates are specifically recognized by a combination of different antibodies. The combined use of these antibodies can be applied to the diagnosis of AD and to defining the structure of the A β 1-42 .
- Hardy, J.A. and Higgins, G.A. (1992) Alzheimer’s disease: The amyloid cascade hypothesis. Science, 256, 184- 185. doi:10.1126/science.1566067
- Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science, 297, 353-356. doi:10.1126/science.1072994
- Jhoo, H., Kim, H.C., Nabeshima, T., Yamada, K., Shin, E.J., Jhoo, W.K., Kim, W., Kang, K.S., Jo, S.A. and Woo, J.I. (2004) Beta-amyloid (1-42)-induced learning and memory deficits in mice: Involvement of oxidative burdens in the hippocampus and cerebral cortex. Behavioural Brain Research, 155, 185-196. doi:10.1016/j.bbr.2004.04.012
- Takahashi, T. and Mihara, H. (2008) Peptide and protein mimetics inhibiting amyloid-peptide aggregation. Accounts of Chemical Research, 41, 1309-1318. doi:10.1021/ar8000475
- LeVine 3rd, H. (1993) Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Science, 2, 404-410. doi:10.1002/pro.5560020312
- Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A. and Klein, W.L. (2003) Alzheimer’s disease-affected brain: Presence of oligomeric Abeta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proceedings of the National Academy of Sciences USA, 100, 10417-10422. doi:10.1073/pnas.1834302100
- Barghorn, S., Nimmrich, V., Striebinger A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R.S., Harlan, J., Barlow, E., Ebert, U. and Hillen, H. (2005) Globular amyloid beta-peptide oligomer—A homogenous and stable neuropathological protein in Alzheimer’s disease. Journal of Neurochemistry, 95, 834-847. doi:10.1111/j.1471-4159.2005.03407.x
- Matsumura, S., Shinoda, K., Yamada, M., Yokojima, S., Inoue, M., Ohnishi, T., Shimada, T., Kikuchi, K., Masui, D., Hashimoto, S., Sato, M., Ito, A., Akioka, M., Takagi, S., Nakamura, Y., Nemoto, K., Hasegawa, Y., Takamoto, H., Inoue, H., Nakamura, S., Nabeshima, Y., Teplow, D.B., Kinjo, M. and Hoshi, M. (2011) Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. Journal of Biological Chemistry, 286, 11555-11562. doi:10.1074/jbc.M110.181313
- Bieschke, J., Herbst, M., Wiglenda, T., Friedrich, R.P., Boeddrich, A., Schiele, F., Kleckers, D., Lopez Del Amo, J.M., Grüning, B.A., Wang, Q., Schmidt, M.R., Lurz, R., Anwyl, R., Schnoegl, S., Fändrich, M., Frank, R.F., Reif, B., Günther, S., Walsh, D.M. and Wanker, E.E. (2011) Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. Nature Chemical Biology, 20, 93-101. doi:10.1038/nchembio.719